United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $137.23 to a high of $142.18. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $140.43 on volume of 143,000 …
United Therapeutics (UTHR) entered into an exclusive license agreement with Corsair Pharma. Collaboration agreements announced by companies like Sangamo (SGMO) and the submission of a regulatory application for GW's Epidiolex …
NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating …
Given up for dead just weeks ago the biotech sector is suddenly back with a vengeance. Seemingly everyone’s favorite …
Description: United Therapeutics develops and makes medicines for cardiovascular conditions, cancer and infectious diseases. Developments: Executives at United Therapeutics are hoping this year will be as good as 2004. Last year the …